Trials / Completed
CompletedNCT02045823
OCT Agreement and Precision Study
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Agreement and Precision Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2014-01-27
- Last updated
- 2022-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02045823. Inclusion in this directory is not an endorsement.